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Seriousconsiderationisneededaboutwhichnon-communicable
diseases to discuss at this month’s United Nations meeting if
people in low income countries are to benefit.
1 The diseases
selected are more problematic in high income than in low
income countries. Stroke, heart disease, diabetes, and chronic
obstructive lung disease primarily affect older adults while low
incomecountriesremainlargelypopulatedbyyouth.According
to World Health Organization data,
2 upper middle income
countries stand to benefit most if comparing the burden of
non-communicable diseases that would be addressed in the
proposed agenda with the burden that would not be addressed
using age adjusted mortality.
The risk factors targeted are also more prevalent in high and
upper middle income countries. Tobacco, alcohol, and obesity
are to some extent luxuries that are not yet affordable to the
poorestpeopleintheworld(table⇓).Targetingriskfactorswhere
they are less prevalent will be less efficient.
The table⇓ raises additional interesting questions that won’t be
addressed. For example, given that some risk factors for
hypertension (such as obesity and physical inactivity) are
comparatively low in low income countries, why are
hypertensionratesfairlysimilar?Furthermore,thetargetedrisk
factors apply to these conditions in higher income countries.
Risk factors for the same conditions are likely to be different
in low income countries and won’t be considered in this “one
size fits all” approach. Substantial evidence suggests that early
deprivation and environmental exposures affect adult health,
3
but these will not be explored in the proposed programme.
Invitations for the meeting had not been extended to selected
delegatesinAugust.
4Themeetinghasreportedlygone“wobbly”
partly because countries in Africa don’t want to be diverted
from today’s immediate health burden to address health
problems they may have tomorrow. Indeed, the programme’s
narrowproposedfocusmayhavenegativeconsequencesforthe
people it aims to help.
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Table 1| Prevalence by income of risk factors targeted in proposed non-communicable disease programme.* Values are mean percentages
of population unless stated otherwise
Hypertension
(n=133)
Physically inactive
(n=122)
Raised blood glucose
(n=101)
Tobacco use (n=152) Obesity (n=163) Mean annual alcohol
consumption (L) (n=188)
Country GDP (n=193)
41.0 43.6 6.3 20.9 24.4 9.2 High
42.3 42.6 10.2 21.9 25.8 8.4 Upper Middle
38.0 34.9 23.4 19.1 20.2 5.2 Lower middle
38.0 18.0 3.3 12.4 5.0 3.7 Low
P=0.006 P<0.0001 P=0.0007 P=0.0003 P<0.0001 P<0.0001
*Based on World Health Organization data.
1
GDP=gross domestic product.
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